Berko İlaç Receives COVID-19 Safe Production Center Certificate

Berko Pharmaceutical has earned the "COVID-19 Safe Production Facility Certificate" issued by the Turkish Standards Institution (TSE) through the measures it implemented and applications it introduced in its factory, field operations and head office from the very beginning of the COVID-19 process. Working and producing for over thirty-five years with the vision of "Healthy Tomorrows" for public health, Berko Pharmaceutical earned the right to receive the "COVID-19 Safe Production Facility Certificate" from the Turkish Standards Institution (TSE) through the precautions it took in production and work areas from the time COVID-19 began to be observed in our country, the high-level hygiene measures it implemented for its employees and the applications it developed with all stakeholders in mind during the COVID-19 pandemic that has affected the entire world.

Barış Özyurtlu, Pharmacist and General Manager of Berko Pharmaceutical, made the following statement on the matter: "By successfully passing the inspections of the Turkish Standards Institution, they have earned the right to receive the 'Safe Production Facility Certificate'. He noted that not only during the COVID-19 process, but also in accordance with GMP (Good Manufacturing Practice) standards, hygiene and safety in production facilities are always maintained at the highest levels. Özyurtlu stated, "Within the framework of the mission Berko Pharmaceutical has undertaken, they are proud to once again demonstrate the care and attention they have shown to public health in reaching 'Healthy Tomorrows'."